Canadian conference on managing legal & business risks in clinical trials

NewsGuard 100/100 Score

The nature of clinical trials is constantly changing in the ever-more globalized and adapting market. In this increasingly-scrutinized industry, it is important to maintain a transparent process, to appropriately manage risks and to avoid abuses, in order to get a piece of this multi-billion dollar industry. How? By effectively managing the legal and business risks!

The Canadian Institute's Managing Legal & Business Risks in Clinical Trials in Canada conference will provide you with the novel planning strategies, skills and tips you require to remain at the clinical trials forefront.

Distinguished Faculty Includes:

AstraZeneca Canada Inc.

ethica Clinical Research Inc.

Health Canada

IRB Services

LMC Endocrinology Centres

Pfizer Canada Inc.

St. Michael's Hospital

The Patient Recruiting Agency

Q&T Research

Topics Covered:

Examining the latest legal, regulatory and policy developments and trends - Obtaining informed consent from patients - Gaining insight into the proper use of placebos within clinical trials - Remaining competitive within the Canadian Market for clinical trials

Conference Title: Managing Legal & Business Risks in Clinical Trials in Canada

Date: February 22 & 23, 2010

Location: The Sutton Place Hotel, Toronto

Website: http://www.canadianinstitute.com/clinicaltrials.htm

Source:

CANADIAN INSTITUTE

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis